text
stringlengths 15
247
|
|---|
Prostate, biopsy;
No tumor present
|
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of muscle proper
Note) The specimen includes muscle proper.
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 5%
|
Prostate, biopsy;
No tumor present
|
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, high grade
Note) The specimen includes muscle proper.
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 40%
|
Lung, biopsy;
Adenocarcinoma
|
Urinary bladder, transurethral resection;
1. No tumor present
2. Chronic granulomatous inflammation with foreign body reaction
Note) The specimen does not include muscle proper.
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 9 (5+4), grade group 5, tumor volume: 80%
|
Lung, biopsy;
Adenocarcinoma
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 10%
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 20%), tumor volume: 60%
|
Prostate, biopsy;
No tumor present
|
Lung, biopsy;
Non-small cell carcinoma, favor adenocarcinoma
|
Lung, biopsy;
Adenocarcinoma
|
Stomach, endoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 70%), tumor volume: 30%
|
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
Note) The specimen includes muscle proper.
|
Stomach, endoscopic biopsy;
Adenocarcinoma, poorly differentiated with poorly cohesive carcinoma component
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 20%), tumor volume: 70%
|
Lung, biopsy;
Non-small cell carcinoma, favor adenocarcinoma
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 30%
|
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, low grade
Note) The specimen includes muscle proper.
|
Prostate, biopsy;
No tumor present
|
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma,
with involvement of subepithelial connective tissue
Note) The specimen includes muscle proper.
|
Urinary bladder, transurethral resection;
Non-invasive papillary urothelial carcinoma, low grade
Note) The specimen includes muscle proper.
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 10%
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 40%), tumor volume: 80%
|
Urinary bladder, transurethral resection;
Urothelial carcinoma in situ
Note) The specimen includes muscle proper.
|
Urinary bladder, transurethral resection;
Invasive urothelial carcinoma, with
1) involvement of muscle proper
2) squamous differentiation
Note) The specimen includes muscle proper.
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 80%), tumor volume: 90%
|
Lung, biopsy;
Adenocarcinoma
|
Lung, biopsy;
Non-small cell carcinoma, favor squamous cell carcinoma
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (3+4), grade group 2 (Gleason pattern 4: 10%), tumor volume: 40%
|
Urinary bladder, transurethral resection;
Urothelial carcinoma in situ
Note) The specimen includes muscle proper.
|
Urinary bladder, transurethral resection;
1. Non-invasive papillary urothelial carcinoma, high grade
2. Urothelial carcinoma in situ
Note) The specimen includes muscle proper.
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 5%
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 7 (4+3), grade group 3 (Gleason pattern 4: 90%), tumor volume: 60%
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 40%
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, poorly differentiated
|
Uterine cervix, colposcopic biopsy;
Chronic nonspecific cervicitis
|
Uterine cervix, punch biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
|
Lung, biopsy;
Adenocarcinoma
|
Lung, biopsy;
Squamous cell carcinoma
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Rectum, colonoscopic mucosal resection;
Tubular adenoma with high grade dysplasia
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
with glandular involvement
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, poorly differentiated
|
Uterine cervix, colposcopic biopsy;
Invasive squamous cell carcinoma
|
Colon, colonoscopic biopsy;
Tubular adenoma with high grade dysplasia
|
Uterine cervix, punch biopsy;
Invasive squamous cell carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Lung, biopsy;
Squamous cell carcinoma
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 30%
|
Colon, colonoscopic submucosal dissection;
Tubular adenoma with high grade dysplasia
|
Rectum, colonoscopic biopsy;
Chronic nonspecific inflammation
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Lung, biopsy;
Squamous cell carcinoma
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 9 (4+5), grade group 5, tumor volume: 20%
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 8 (4+4), grade group 4, tumor volume: 100%
|
Uterine cervix, punch biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Lung, biopsy;
Non-small cell carcinoma, not otherwise specified
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
Chronic nonspecific cervicitis
|
Rectum, colonoscopic biopsy;
Tubular adenoma with high grade dysplasia
|
Uterine cervix, colposcopic biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Colon, colonoscopic biopsy;
Chronic nonspecific inflammation
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, well differentiated
|
Uterine cervix, punch biopsy;
Low-grade squamous intraepithelial lesion (LSIL; CIN 1)
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 2)
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 5%
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Uterine cervix, polypectomy biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 100%
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
Endocervical adenocarcinoma, HPV-associated, usual type
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, well differentiated
|
Lung, biopsy;
Small cell carcinoma
|
Colon, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
with glandular involvement
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Prostate, biopsy;
Acinar adenocarcinoma, Gleason's score 6 (3+3), grade group 1, tumor volume: 60%
|
Uterine cervix, colposcopic biopsy;
High-grade squamous intraepithelial lesion (HSIL; CIN 3)
|
Lung, biopsy;
No evidence of malignancy or granuloma
|
Rectum, colonoscopic biopsy;
Adenocarcinoma, moderately differentiated
|
Colon, colonoscopic biopsy;
Chronic active colitis
|
Lung, biopsy;
Adenocarcinoma
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.